Promising Vaccine Candidates
Chemical synthesis of a polypeptide backbone derived from the primary sequence of the cancer protein NY-ESO-1 enabled by kinetically controlled ligation and pseudoprolines.
Harris PW, Brimble MA., Biopolymers. 2015 Feb 5. doi: 10.1002/bip.22621. [Epub ahead of print]
The cancer protein NY-ESO-1 has been shown to be one of the most
promising vaccine candidates although little is known about its
cellular function. Using a chemical protein strategy, the 180 amino
acid polypeptide, tagged with an arginine solubilising tail, was
assembled in a convergent manner from four unprotected peptide α-
thioester peptide building blocks and one cysteinyl polypeptide,
which were in turn prepared by Boc and Fmoc SPPS respectively. To
facilitate the assembly by ligation chemistries, non-native cysteines
were introduced as chemical handles into the polypeptide fragments;
pseudoproline dipeptides and microwave assisted Fmoc SPPS were
crucial techniques to prepare the challenging hydrophobic Cterminal
fragment. Three sequential kinetically controlled ligations,
which exploited the reactivity between peptide arylthioesters and
peptide alkylthioesters, were then used in order to assemble the more
tractable N-terminal region of NY-ESO-1. The ensuing 147 residue
polypeptide thioester then underwent successful final native
chemical ligation with the very hydrophobic C-terminal polypeptide
bearing an N-terminal cysteine affording the 186 residue polypeptide
as an advanced intermediate en route to the native NY-ESO-1
protein. This article is protected by copyright. All rights reserved.
© 2015 Wiley Periodicals, Inc.
Novel Therapeutics For Alcohol Intoxication and Dependence
Oxytocin prevents ethanol actions at {delta} subunit-containing GABAA receptors and attenuates ethanol-induced motor
impairment in rats.Bowen MT, Peters ST, Absalom N, Chebib M, Neumann ID, McGregor IS., PNAS, 2015 Feb
23. doi:10.1073/pnas.1416900112 [Epub ahead of print]
Even moderate doses of alcohol cause considerable impairment
of motor coordination, an effect that substantially involves
potentiation of GABAergic activity at δ subunit-containing
GABAA receptors (δ-GABAARs). Here, we demonstrate that
oxytocin selectively attenuates ethanol-induced motor
impairment and ethanol-induced increases in GABAergic
activity at δ-GABAARs and that this effect does not involve the
oxytocin receptor. Specifically, oxytocin (1 μg i.c.v.) given before
ethanol (1.5 g/kg i.p.) attenuated the sedation and ataxia induced
by ethanol in the open-field locomotor test, wire-hanging test,
and righting-reflex test in male rats. Using two-electrode
voltage-clamp electrophysiology in Xenopus oocytes, oxytocin
was found to completely block ethanol-enhanced activity at
α4β1d and α4β3d recombinant GABAARs. Conversely, ethanol
had no effect when applied to α4β1 or α4β3 cells, demonstrating
the critical presence of the d subunit in this effect. Oxytocin had
no effect on the motor impairment or in vitro effects induced by
the δ-selective GABAAR agonist 4,5,6,7-tetrahydroisoxazolo(5,4-
c)pyridin-3-ol, which binds at a different site on δ-GABAARs
than ethanol. Vasopressin, which is a nonapeptide with
substantial structural similarity to oxytocin, did not alter ethanol
effects at δ-GABAARs. This pattern of results confirms the
specificity of the interaction between oxytocin and ethanol at δ-
GABAARs. Finally, our in vitro constructs did not express any
oxytocin receptors, meaning that the observed interactions occur
directly at δ-GABAARs. The profound and direct interaction
observed between oxytocin and ethanol at the behavioral and
cellular level may have relevance for the development of novel
therapeutics for alcohol intoxication and dependence.
Big Spider, Big Potential
Engineering Potent and Selective Analogs of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel
Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H, Andrews KL, Moyer BD, McDonough SI, Favreau P, Stöcklin R, Miranda LP., J.
Med. Chem., Just Accepted Manuscript
DOI: 10.1021/jm501765v
Publication Date (Web): February 6, 2015
Copyright © 2015 American Chemical Society
NaV1.7 is a voltage-gated sodium ion channel implicated by
human genetic evidence as a therapeutic target for the treatment
of pain. Screening fractionated venom from the tarantula
Grammostola porteri led to the identification of a 34-
residue peptide, termed GpTx-1, with potent activity on NaV1.7
(IC50 = 10 nM) and promising selectivity against key NaV
subtypes (20x and 1000x over NaV1.4 and NaV1.5, respectively).
NMR structural analysis of the chemically synthesized three
disulfide peptide was consistent with an inhibitory cystine knot
motif. Alanine scanning of GpTx-1 revealed that residues Trp29,
Lys31, and Phe34 near the C-terminus are critical for potent
NaV1.7 antagonist activity. Substitution of Ala for Phe at
position 5 conferred three hundred-fold selectivity against
NaV1.4. A structure-guided campaign afforded additive
improvements in potency and NaV subtype selectivity,
culminating in the design of [Ala5,Phe6,Leu26,Arg28]GpTx-1
with a NaV1.7 IC50 value of 1.6 nM and >1000x selectivity
against NaV1.4 and NaV1.5.
One Step Closer to a Cure
Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling.
Yoshino Y, Ishisaka M, Tsujii S, Shimazawa M, Hara H., Biochem Biophys Res. Commun. ,2015 Feb 7. doi: 10.1016/j.bbrc.2015.01.098.
[Epub ahead of print]
Alzheimer's disease (AD) is a common neurodegenerative
disease characterized by cognitive dysfunction and neuronal cell
death in the hippocampus and cerebral cortex. Glucagonlike
peptide-1 (GLP-1) is an insulinotropic peptides. GLP-1-
associated medicines are widely used as treatments for type 2
diabetes. In addition, they have been shown to ameliorate
pathology in AD mouse models. Here, we investigated the effects
of GLP-1 on different stressors in murine hippocampal HT22
cells. GLP-1 (7-36)prevented H2O2-, l-glutamate-, tunicamycin-,
thapsigargin-, and amyloid β1-42-induced neuronal cell death in a
concentration-dependent manner. GLP-1 (7-36) treatment for
1 h significantly increased phosphorylated Akt and extracellular
signal-regulated kinase 1 and 2 (ERK1/2) when compared with
vehicle-treatment. These results suggest that GLP-1 (7-36) is
protective against these stressors via activation of survival
signaling molecules, such as Akt and ERK1/2 in HT22 cells. In
conclusion, GLP-1 and activators of the GLP-1 receptor might
be useful targets for the treatment of AD.
Copyright © 2015 Elsevier Inc. All rights reserved.
Glucagon-Like Peptide-1
(7-36)
Glucagon-Like Peptide-1 (7-36) [GLP-1 (7-36)] has shown potential in the treatment of type II diabetes. For example, it restores myocardial insulin sensitivity and prevents progressive heart failure.
(Chen M, et al. Cardiovasc. Diabetol., 2014, 13, 115)
GLP-(7-36) also has protective effects in the brain. It has protective effects on brain ischemia/reperfusion damage in diabetic rats.
(Zhao L, et al., Brain Res., 2015 Jan. 16. doi: 10.1016/j.brainres.2015.01.014 [Epub. ahead of print]) and protects synaptic and learning functions from neuroinflammation in rodents (Iwai T, et al., J. Neurosci. Res., 2014, 92, 946-54).
Administered intrathecally, GLP-1(7-36) suppresses pain hypersensitivity.
(Gong N, et al, J. Neurosci, 2014, 34, 5322-34)
AAPPTec offers glucagon-like peptide-1 (7-36) for research applications.
P001753 |
GLP-1 (7-36) amide, human |
1mg |
$300 |
5mg |
$900 |
10mg |
$1620 |
4-Cyanophenylalanine
4-Cyanophenylalanine residues may be utilized as non-invasive
fluorescent and IR probes. 4-Cyanophenylalanine residues have
been used as probes in 2D IR spectroscopy (Urbanek DC, et al., J. Phys. Chem.
Lett., 2010, 1, 3311-5; Chung JK, et al., J. Am. Chem. Soc. , 2012,
134, 12118-24). The 4-cyanophenylalanine is easily
substituted for a phenylalanine residue in synthetic peptides.
Methods of genetically encoding 4-cyanophenylalanine have also
been developed ( Schultz KC, et al., J. Am. Chem. Soc., 2006,
128, 13984-5). EJ Petersson and coworkers have utilized 4-
cyanophenylalanine with backbone thioamides as FRET pairs
(Goldberg JM, et al., J. Am. Chem. Soc., 2010, 132, 14718-20;
Wissner, EF, et al., J. Am. Chem. Soc., 2013, 135, 6529-40).
AAPPTec offers Boc-protected, Fmoc-protected, or unprotected L-4-cyanophenylalanine for use in structural studies. These products are available in convenient catalog quantities or you may request a bulk quotation by email to sales@aapptec.com.
UBF119 |
Boc-Phe(4-CN)-OH |
1g |
$60
$230
|
UFF119 |
Fmoc-Phe(4-CN)-OH |
1g
5g
|
$75
$300
|
UHF119 |
H-Phe(4-CN)-OH |
1g
5g
|
$85
$330
|
Disomers are also available from AAPPTec. |
|
AAPPTec:
Your Complete
Peptide Source
Custom Peptides
AAPPTec provides high
quality custom peptides
quickly at very competitive
prices. Our peptide chemists
have prepared peptides with up
to 80 to 100 residues in high
purity. They have decades of
experience preparing and
purifying all types of peptides,
including hydrophobic
peptides, cyclized peptides and
peptides conjugated to biotin,
fatty acids or dyes. Most
modifications, such as
phosphorylation, unusual
amino acids, side chain labels
and fluorescent tags, can be
incorporated.
To request a quotation for
custom peptides, email your
sequences, the quantity of each
peptide and the purity you
require to info@aapptec.com or use our convenient online
quotation request form at www.aapptec.com.
Pseudoproline Dipeptides
Pseudoproline dipeptides
have many uses in peptide
synthesis. They are often
utilized in the synthesis of
difficult, hydrophobic
sequences. The
pseudoproline structure
imposes a bend in the peptide
backbone that disrupts
hydrogen bonding patterns
of the peptide and reduces
the tendency of the peptide
chain to aggregate.
The ability of the
pseudoproline to promote a
bend in the peptide structure
facilitates ring formation in
peptides. The pseudoproline
can be incorporated as a
temporary turn-inducing
element to promote the
cyclization of a peptide. Final
deprotection of the peptide
converts the pseudoproline
back to a native serine or
threonine residue.
Since pseudoprolines can be
coupled with little to no
racemization, pseudoprolines
are very useful as the Cterminal
residue in peptide
fragments that will be coupled
in solution phase reactions.
AAPPTec has the largest selection of pseudoproline dipeptides at very competitive prices. To view AAPPTec’s prices and complete list of pseudoproline dipeptides,
please go to our web site at http://www.aapptec.com/-c-
57.html.
Oxytocin
Oxytocin acts both as a
hormone and a
neurotransmitter in the
brain. The primary effects of
oxytocin are uterine
contraction and facilitating
milk production in lactating
mothers. It is used to induce
labor and toaid milk
production in breast-feeding
mothers. Due to its
structural similarity to
vasopressin, oxytocin can
reduce the production of
urine slightly and in some
species it can stimulate
sodium excretion by the
kidneys. Under certain
circumstances, it can inhibit
the release of
adrenocorticotropic hormone
and cortisol indirectly.
In the brain, oxytocin is
associated with sexual
arousal and pair bonding
with her sexual mate in
females. Oxytocin crosses
the placenta and enters the
brain of the fetus where it
induces a switch in the effect
of GABA from excitatory to
inhibitory. This silences the
fetal brain and reduces its
vulnerability to hypoxic
damage during birth. After
birth, oxytocin appears to be
responsible for maternal
behavior. Oxytocin is also
plays a role in the social
behaviors of many species; in
humans it appears to
increase trust, reduce fear
and increase empathy.
Autistic child have been
found to have significantly
lower levels of oxytocin in
their blood. Administered
intravenously, oxytocin
decreases repetitive
behaviors and helps autistic
adults to evaluate the
emotional significance of
speech intonation.
Oxytocin for research applications is available from AAPPTec.
P002203 |
Oxytocin |
5mg |
$90 |
10mg |
$150 |
Apex 396 HT Library Synthesizer
The Apex 396 HT is
unsurpassed for highthroughput
synthesis of peptide
libraries. It synthesizes up to
192 different sequences at the
same time using standard 1 mL
well titer plates.
The Apex 396 HT is ideal for
SAR studies. It can prepare
complete alanine scan libraries,
deletion libraries and
truncation libraries to identify
critical segments and residues.
The library peptides are
cleaved into standard 96 well
titer plates.
APS 2015 in Orlando, Florida!
AAPPTec will be at the American Peptide Symposium in Orlando, Florida this year from June 20-25, 2015!
Guests can receive a free gift just by stopping by our booth!
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylananine
Xhindoli D, Morgera F, Zinth U, Rizzo R, Pacor S, Tossi A., Biochem. J., 2015, 465, 443-57. doi: 10.1042/BJ20141016
The human cathelicidin peptide LL-37 is an important effector
of our innate immune system and contributes to host defense
with direct antimicrobialactivity and immunomodulatory
properties, and by stimulating wound healing. Its sequence has
evolved to confer specific structural characteristics that strongly
affect these biological activities, and differentiate it from
orthologues of other primate species. In the present paper we
report a detailed study of the folding and self-assembly of
this peptide in comparison with rhesus monkey peptide RL-37,
taking into account the different stages of its trajectory from
bulk solution to contact with, and insertion into, biological
membranes. Phenylalanineresidues in different positions
throughout the native sequences of LL-37 and RL-37 were
systematically replaced with the non-invasive fluorescent and IR
probe p-cyanophenylalanine. Steady-state and time-resolved
fluorescence studies showed that LL- 37, in contrast to RL-37,
forms oligomers with a loose hydrophobic core in physiological
solutions, which persist in the presence of biological membranes.
Fourier transform IR and surface plasmon resonance studies
also indicated different modes of interaction for LL-37 and RL-
37 with anionic and neutral membranes. This correlated with a
distinctly different mode of bacterial membrane
permeabilization, as determined using a flow cytometric method
involving impermeant fluorescent dyes linked to polymers of
defined sizes.
|